Eculizumab effectively reduced MG-ADL scores and corticosteroid use in thymoma-associated myasthenia gravis patients by week 12. The monoclonal antibody targets complement protein C5, preventing ...

3 Research on MG genetic heterogeneity and subtype-specific genetic factors Different MG subtypes exhibit significant clinical heterogeneity. EOMG, LOMG, thymoma-associated MG, and anti-MuSK ...

Ravulizumab had an early and sustained clinical effect which contributed to the avoidance of intubation. A patient with thymoma-associated myasthenia gravis (MG) was successfully treated with ...

CBX-12 is under clinical development by Cybrexa and currently in Phase II for Thymoma (Thymic Epithelial Tumor). According to GlobalData, Phase II drugs for Thymoma (Thymic Epithelial Tumor) does not ...

The histologic appearance was considered most compatible with a diagnosis of thymoma. However, the differential diagnosis was fairly broad and included lymphoma, medullary thyroid carcinoma ...

Cancer that starts in the thymus gland is called thymus cancer. It starts when cells in the thymus gland grow out of control and crowd out normal cells. Thymus cancers are rare. The thymus is a small ...